Safety & Pharmacovigilance

Our experienced global pharmacovigilance professionals help you ensure safety through all stages of clinical development.

Safety monitoring services tailored precisely to your needs

Biotech companies have specific and demanding clinical safety requirements. Because we’re Built for Biotech℠, we design safety and pharmacovigilance services that exactly fit the needs of both your product and study – and we’re agile and flexible enough to adapt as they do.

Study-specific services

We manage the clinical safety process from triage through case processing, narrative writing, and submission to competent authorities and ethics committees, supported by a comprehensive framework of standard operating procedures (SOPs) and study-specific safety plans. Our services include:

Medical triage of serious adverse events
Case processing
Narrative writing
Medical review and assessment
Risk/benefit assessments
Submissions to competent authorities, ethics committees, and sites
Development safety update report writing
Signal detection

Portfolio services

Many of our biotech customers start with a safety database at the study level and later make the decision to invest in a global safety database. By pooling all of the safety data into one safety database and one dataset, we’re able to better optimize signal detection and risk/benefit assessments. Premier Research can manage the migration of all your portfolio safety data into a dedicated global safety database while maintaining and archiving your data for as long as you need.

Consultancy services

Even the best safety team can benefit from additional support, so Premier Research’s pharmacovigilance experts work with our regulatory and medical writing teams to provide flexible solutions for short-term and limited-scope services, including:

Aggregate report writing
PV SOP and procedure writing
Risk management plans
Literature searches and reports
Inspection readiness audits
Preparation of reference safety information
Risk/benefit statements
Medical review of individual case study reports
Signal detection
General consulting and regulatory advice

PREMIER PERSPECTIVE

Safety considerations for emerging therapies

Sponsors of emerging hematologic therapies – including gene transfer and gene editing, adoptive cellular, and antibody-drug conjugates – face a unique set of challenges in conducting early-phase, dose-finding studies.

Learn More

PREMIER PERSPECTIVE

Special considerations for medical device trials

To ensure the safety and efficacy of these devices, regulators expect device manufacturers to provide data that accurately reflect the risk profile of the device. As such, the regulatory guidelines for devices are distinct from those governing drugs, particularly in the area of safety.

Learn More

Related Services

Safety and pharmacovigilance is part of a wide range of service offerings that include medical affairs, medical writing, and regulatory consulting. Follow the links below to learn more about how clients gain from our specialized expertise.